Selected research
Industry Research
Nystatin Industry Research Report 2026
Market perspective
The global Nystatin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nystatin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nystatin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nystatin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nystatin include 3B Scientific, BeiJing Hwrk Chemicals, Beijing NuoqiYa Biotechnology, BEST-REAGENT, BOC Sciences, Fishfa Biogenics, HBCChem, J & K SCIENTIFIC and LGM Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nystatin market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nystatin Market by Company
3B Scientific
BeiJing Hwrk Chemicals
Beijing NuoqiYa Biotechnology
BEST-REAGENT
BOC Sciences
Fishfa Biogenics
HBCChem
J & K SCIENTIFIC
LGM Pharma
Pure Chemistry Scientific
Toronto Research Chemicals
Waterstone Technology
XiaoGan ShenYuan ChemPharm
Olon S.p.A
Guangzhou Tosun Pharmaceutical
Pfizer
Concord Biotech
BrightGene Bio-Medical Technology
Antibiotice SA
Shanghai Minbiotech
Zhejiang Huida Biotech
Centrient Pharmaceuticals
Nystatin Segment by Type
USP Grade
Research Grade
Others
Nystatin Segment by Application
Skin
Oral Cavity
Others
Nystatin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nystatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nystatin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nystatin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nystatin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nystatin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nystatin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- USP Grade
- Research Grade
- Others
Applications
- Skin
- Oral Cavity
- Others
Companies covered
- 3B Scientific
- BeiJing Hwrk Chemicals
- Beijing NuoqiYa Biotechnology
- BEST-REAGENT
- BOC Sciences
- Fishfa Biogenics
- HBCChem
- J & K SCIENTIFIC
- LGM Pharma
- Pure Chemistry Scientific
- Toronto Research Chemicals
- Waterstone Technology
- XiaoGan ShenYuan ChemPharm
- Olon S.p.A
- Guangzhou Tosun Pharmaceutical
- Pfizer
- Concord Biotech
- BrightGene Bio-Medical Technology
- Antibiotice SA
- Shanghai Minbiotech
- Zhejiang Huida Biotech
- Centrient Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nystatin Market Size (2021-2032)
- 2.2.2 Global Nystatin Sales (2021-2032)
- 2.2.3 Global Nystatin Market Average Price (2021-2032)
- 2.3 Nystatin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 USP Grade
- 2.3.3 Research Grade
- 2.3.4 Others
- 2.4 Nystatin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Skin
- 2.4.3 Oral Cavity
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nystatin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nystatin Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Nystatin Revenue of Manufacturers (2021-2026)
- 3.4 Global Nystatin Average Price by Manufacturers (2021-2026)
- 3.5 Global Nystatin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nystatin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nystatin, Product Type & Application
- 3.8 Global Manufacturers of Nystatin, Established Date
- 3.9 Global Nystatin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 3B Scientific
- 4.1.1 3B Scientific Company Information
- 4.1.2 3B Scientific Business Overview
- 4.1.3 3B Scientific Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 3B Scientific Nystatin Product Portfolio
- 4.1.5 3B Scientific Recent Developments
- 4.2 BeiJing Hwrk Chemicals
- 4.2.1 BeiJing Hwrk Chemicals Company Information
- 4.2.2 BeiJing Hwrk Chemicals Business Overview
- 4.2.3 BeiJing Hwrk Chemicals Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BeiJing Hwrk Chemicals Nystatin Product Portfolio
- 4.2.5 BeiJing Hwrk Chemicals Recent Developments
- 4.3 Beijing NuoqiYa Biotechnology
- 4.3.1 Beijing NuoqiYa Biotechnology Company Information
- 4.3.2 Beijing NuoqiYa Biotechnology Business Overview
- 4.3.3 Beijing NuoqiYa Biotechnology Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Beijing NuoqiYa Biotechnology Nystatin Product Portfolio
- 4.3.5 Beijing NuoqiYa Biotechnology Recent Developments
- 4.4 BEST-REAGENT
- 4.4.1 BEST-REAGENT Company Information
- 4.4.2 BEST-REAGENT Business Overview
- 4.4.3 BEST-REAGENT Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BEST-REAGENT Nystatin Product Portfolio
- 4.4.5 BEST-REAGENT Recent Developments
- 4.5 BOC Sciences
- 4.5.1 BOC Sciences Company Information
- 4.5.2 BOC Sciences Business Overview
- 4.5.3 BOC Sciences Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BOC Sciences Nystatin Product Portfolio
- 4.5.5 BOC Sciences Recent Developments
- 4.6 Fishfa Biogenics
- 4.6.1 Fishfa Biogenics Company Information
- 4.6.2 Fishfa Biogenics Business Overview
- 4.6.3 Fishfa Biogenics Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Fishfa Biogenics Nystatin Product Portfolio
- 4.6.5 Fishfa Biogenics Recent Developments
- 4.7 HBCChem
- 4.7.1 HBCChem Company Information
- 4.7.2 HBCChem Business Overview
- 4.7.3 HBCChem Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 HBCChem Nystatin Product Portfolio
- 4.7.5 HBCChem Recent Developments
- 4.8 J & K SCIENTIFIC
- 4.8.1 J & K SCIENTIFIC Company Information
- 4.8.2 J & K SCIENTIFIC Business Overview
- 4.8.3 J & K SCIENTIFIC Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 J & K SCIENTIFIC Nystatin Product Portfolio
- 4.8.5 J & K SCIENTIFIC Recent Developments
- 4.9 LGM Pharma
- 4.9.1 LGM Pharma Company Information
- 4.9.2 LGM Pharma Business Overview
- 4.9.3 LGM Pharma Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 LGM Pharma Nystatin Product Portfolio
- 4.9.5 LGM Pharma Recent Developments
- 4.10 Pure Chemistry Scientific
- 4.10.1 Pure Chemistry Scientific Company Information
- 4.10.2 Pure Chemistry Scientific Business Overview
- 4.10.3 Pure Chemistry Scientific Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pure Chemistry Scientific Nystatin Product Portfolio
- 4.10.5 Pure Chemistry Scientific Recent Developments
- 4.11 Toronto Research Chemicals
- 4.11.1 Toronto Research Chemicals Company Information
- 4.11.2 Toronto Research Chemicals Business Overview
- 4.11.3 Toronto Research Chemicals Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Toronto Research Chemicals Nystatin Product Portfolio
- 4.11.5 Toronto Research Chemicals Recent Developments
- 4.12 Waterstone Technology
- 4.12.1 Waterstone Technology Company Information
- 4.12.2 Waterstone Technology Business Overview
- 4.12.3 Waterstone Technology Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Waterstone Technology Nystatin Product Portfolio
- 4.12.5 Waterstone Technology Recent Developments
- 4.13 XiaoGan ShenYuan ChemPharm
- 4.13.1 XiaoGan ShenYuan ChemPharm Company Information
- 4.13.2 XiaoGan ShenYuan ChemPharm Business Overview
- 4.13.3 XiaoGan ShenYuan ChemPharm Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 XiaoGan ShenYuan ChemPharm Nystatin Product Portfolio
- 4.13.5 XiaoGan ShenYuan ChemPharm Recent Developments
- 4.14 Olon S.p.A
- 4.14.1 Olon S.p.A Company Information
- 4.14.2 Olon S.p.A Business Overview
- 4.14.3 Olon S.p.A Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Olon S.p.A Nystatin Product Portfolio
- 4.14.5 Olon S.p.A Recent Developments
- 4.15 Guangzhou Tosun Pharmaceutical
- 4.15.1 Guangzhou Tosun Pharmaceutical Company Information
- 4.15.2 Guangzhou Tosun Pharmaceutical Business Overview
- 4.15.3 Guangzhou Tosun Pharmaceutical Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Guangzhou Tosun Pharmaceutical Nystatin Product Portfolio
- 4.15.5 Guangzhou Tosun Pharmaceutical Recent Developments
- 4.16 Pfizer
- 4.16.1 Pfizer Company Information
- 4.16.2 Pfizer Business Overview
- 4.16.3 Pfizer Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Pfizer Nystatin Product Portfolio
- 4.16.5 Pfizer Recent Developments
- 4.17 Concord Biotech
- 4.17.1 Concord Biotech Company Information
- 4.17.2 Concord Biotech Business Overview
- 4.17.3 Concord Biotech Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Concord Biotech Nystatin Product Portfolio
- 4.17.5 Concord Biotech Recent Developments
- 4.18 BrightGene Bio-Medical Technology
- 4.18.1 BrightGene Bio-Medical Technology Company Information
- 4.18.2 BrightGene Bio-Medical Technology Business Overview
- 4.18.3 BrightGene Bio-Medical Technology Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 BrightGene Bio-Medical Technology Nystatin Product Portfolio
- 4.18.5 BrightGene Bio-Medical Technology Recent Developments
- 4.19 Antibiotice SA
- 4.19.1 Antibiotice SA Company Information
- 4.19.2 Antibiotice SA Business Overview
- 4.19.3 Antibiotice SA Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Antibiotice SA Nystatin Product Portfolio
- 4.19.5 Antibiotice SA Recent Developments
- 4.20 Shanghai Minbiotech
- 4.20.1 Shanghai Minbiotech Company Information
- 4.20.2 Shanghai Minbiotech Business Overview
- 4.20.3 Shanghai Minbiotech Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Shanghai Minbiotech Nystatin Product Portfolio
- 4.20.5 Shanghai Minbiotech Recent Developments
- 4.21 Zhejiang Huida Biotech
- 4.21.1 Zhejiang Huida Biotech Company Information
- 4.21.2 Zhejiang Huida Biotech Business Overview
- 4.21.3 Zhejiang Huida Biotech Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Zhejiang Huida Biotech Nystatin Product Portfolio
- 4.21.5 Zhejiang Huida Biotech Recent Developments
- 4.22 Centrient Pharmaceuticals
- 4.22.1 Centrient Pharmaceuticals Company Information
- 4.22.2 Centrient Pharmaceuticals Business Overview
- 4.22.3 Centrient Pharmaceuticals Nystatin Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Centrient Pharmaceuticals Nystatin Product Portfolio
- 4.22.5 Centrient Pharmaceuticals Recent Developments
5 Global Nystatin Market Scenario by Region
- 5.1 Global Nystatin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nystatin Sales by Region: 2021-2032
- 5.2.1 Global Nystatin Sales by Region: 2021-2026
- 5.2.2 Global Nystatin Sales by Region: 2027-2032
- 5.3 Global Nystatin Revenue by Region: 2021-2032
- 5.3.1 Global Nystatin Revenue by Region: 2021-2026
- 5.3.2 Global Nystatin Revenue by Region: 2027-2032
- 5.4 North America Nystatin Market Facts & Figures by Country
- 5.4.1 North America Nystatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nystatin Sales by Country (2021-2032)
- 5.4.3 North America Nystatin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Nystatin Market Facts & Figures by Country
- 5.5.1 Europe Nystatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nystatin Sales by Country (2021-2032)
- 5.5.3 Europe Nystatin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Nystatin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nystatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nystatin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nystatin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nystatin Market Facts & Figures by Country
- 5.7.1 South America Nystatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nystatin Sales by Country (2021-2032)
- 5.7.3 South America Nystatin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Nystatin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nystatin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nystatin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nystatin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Nystatin Sales by Type (2021-2032)
- 6.1.1 Global Nystatin Sales by Type (2021-2032) & (t)
- 6.1.2 Global Nystatin Sales Market Share by Type (2021-2032)
- 6.2 Global Nystatin Revenue by Type (2021-2032)
- 6.2.1 Global Nystatin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nystatin Revenue Market Share by Type (2021-2032)
- 6.3 Global Nystatin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nystatin Sales by Application (2021-2032)
- 7.1.1 Global Nystatin Sales by Application (2021-2032) & (t)
- 7.1.2 Global Nystatin Sales Market Share by Application (2021-2032)
- 7.2 Global Nystatin Revenue by Application (2021-2032)
- 7.2.1 Global Nystatin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nystatin Revenue Market Share by Application (2021-2032)
- 7.3 Global Nystatin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nystatin Value Chain Analysis
- 8.1.1 Nystatin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nystatin Production Mode & Process
- 8.2 Nystatin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nystatin Distributors
- 8.2.3 Nystatin Customers
9 Global Nystatin Analyzing Market Dynamics
- 9.1 Nystatin Industry Trends
- 9.2 Nystatin Industry Drivers
- 9.3 Nystatin Industry Opportunities and Challenges
- 9.4 Nystatin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst